Zoeti a Aktie

178,31USD 1,56USD 0,88%
Zoeti a für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A1KBYX / ISIN: US98978V1035
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,92
The Vanguard Group, Inc. 8,90
Vanguard Group, Inc. (Subfiler) 8,65
State Street Corp. 4,37
State Farm Investment Management Corp. 3,54
AllianceBernstein LP 3,40
BlackRock Fund Advisors 2,88
Vanguard Total Stock Market ETF 2,84
Vanguard 500 Index Fund 2,65
Geode Capital Management LLC 2,30
BlackRock Institutional Trust Co. NA 2,22
Managed Account Advisors LLC 2,04
Capital Research & Management Co. (World Investors) 1,48
Polen Capital Management LLC 1,41
Fidelity 500 Index Fund 1,23

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 10 600 11 300 12 100 13 800 14 100
Umsatz pro Mitarbeiter in Mio. EUR 0,59 0,59 0,64 0,59 0,61

Bilanz (in Mio. USD) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 4 748 6 611 6 930 7 506 6 343
Summe Anlagevermögen 6 797 6 998 6 970 7 419 7 943
Summe Aktiva 11 545 13 609 13 900 14 925 14 286

Bilanz (in Mio. USD) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 6 646 7 402 6 784 8 133 6 803
Summe Fremdkapital 8 837 9 836 9 356 10 522 9 295
Summe Eigenkapital 2 708 3 773 4 544 4 403 4 991
Summe Passiva 11 545 13 609 13 900 14 925 14 286

Adresse

10 Sylvan Way, 07054 Parsippany
Telefon +1 (973) 822-7000
Internet http://www.zoetis.com

Management

Abhay Nayak
Head-Strategy & Accelerated Growth Businesses
Antoinette R. Leatherberry
Independent Director
Frank A. D'Amelio
Independent Director
Gavin D. K. Hattersley
Director
Gregory Norden
Independent Director
Jamie Andrew Brannan
Chief Commercial Officer
Keith Sarbaugh
Executive VP, Chief Digital & Technology Officer
Kristin C. Peck
Chief Executive Officer & Director
Louise M. Parent
Independent Director
Michael B. McCallister
Non-Executive Chairman
Mike McFarland
Chief Medical Officer & Executive Vice President
Paul M. Bisaro
Independent Director
Rimma Driscoll
EVP, Head-Global Strategy & Business Development
Robert J. Polzer
President-Research & Development, Executive VP
Robert W. Scully
Independent Director
Roxanne Lagano
Secretary, CHRO, Executive VP & General Counsel
Sanjay Khosla
Independent Director
Steven Frank
Head-Investor Relations
Vanessa A. Broadhurst
Independent Director
Wetteny Joseph
CFO, EVP & Head-Business Development
William Dorsey
Head-US Operations
Willie M. Reed
Independent Director